21 May 2026Open access
Pharmacogenomic landscape of a Moroccan cohort: enhancing global diversity and addressing the North African gapPublisher siteScientific Reports, Pharmacogenetics and Drug Metabolism
Active, last published 2026
In sars-cov-2 and covid-19 research
Mohammed
Hakmi
Scholar“Research focused on SARS-CoV-2 and COVID-19 Research and adjacent fields.”
Mohammed V University
Morocco
Claim Your ProfileMorocco9
H-index
436
Citations
Mohammed has not officially claimed their profile. If you are Mohammed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohammed Hakmi is a researcher working on SARS-CoV-2 and COVID-19 Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohammed's work has been cited 436 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
SARS-CoV-2 and COVID-19 Research×12Computational Drug Discovery Methods×9vaccines and immunoinformatics approaches×5Genetic Associations and Epidemiology×4Estrogen and related hormone effects×4
04 · Where I am
Affiliations
Affiliation on published researchMohammed V University, MoroccoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
11 works30 Apr 2026Open access
Genomic and structural analysis of the endocannabinoid system in Moroccans: A novel CNR1 variant (V392A) impairs CB1 receptor stabilityPublisher sitePLoS ONE, Cannabis and Cannabinoid Research
28 Mar 2026Open access
The impact of PD-1 mutations on pembrolizumab binding: insights from molecular dynamics and MM-GBSA analysisPublisher siteScientific Reports, Cancer Immunotherapy and Biomarkers
15 Dec 2025
Deciphering Glutathione S‐Transferase <scp>P1</scp> Inhibition Mechanisms for Overcoming Cancer Chemoresistance: Insights From Computational AnalysisPublisher siteProteins Structure Function and Bioinformatics
27 Sept 2025
Eudesma-4(15), 7-dien-1-β-ol, A promising natural drug candidate for Alzheimer's disease targeting the NMDA pathway: GC-MS identification, molecular docking, pharmacokinetic and molecular dynamic analysisPublisher siteComputers in Biology and Medicine, Cholinesterase and Neurodegenerative Diseases
28 Apr 20251cites
Phytochemical Inhibitors of SARS‐CoV‐2 Entry: Targeting the ACE2‐RBD Interaction with <scp>l</scp>‐Tartaric Acid, <scp>l</scp>‐Ascorbic Acid, and <i>Curcuma longa</i> ExtractPublisher siteChemistrySelect, Vitamin C and Antioxidants Research
9 Dec 2024Open access9cites
Chemical composition, antimicrobial, and antioxidant properties of essential oils from Artemisia herba-alba asso. and Artemisia huguetii caball. from Morocco: in vitro and in silico evaluationPublisher siteFrontiers in Chemistry, Essential Oils and Antimicrobial Activity
1 Oct 2024Open access
Moroccan genome project: Genomic insight into a North African populationPublisher siteExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohammed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you